CIMT Lifetime Achievement Award for Hans-Georg Rammensee
The German immunologist Hans-Georg Rammensee is the recipient of the 2023 CIMT Lifetime Achievement Award. He is recognized for his extraordinary achievements in cancer immunology, in particular the understanding of peptide-antigen presentation on MHC molecules and his seminal work on personalized cancer vaccination.
In addition to his scientific contributions, Professor Rammensee has been an inspiring mentor to many young researchers and has worked tirelessly to promote collaboration and cooperation within the scientific community.
Hans-Georg Rammensee is the director of the Department of Immunology at the University of Tübingen.
The prize, which is awarded every other year by the Association for Cancer Immunotherapy CIMT, honors European scientists who have made significant contributions to cancer immunotherapy research and education throughout their careers.
The Association for Cancer Immunotherapy will honor Hans-Georg Rammensee on the evening of Thursday, May 4, at 6 p.m., in Mainz, Germany at the 20th Annual Meeting of the Association for Cancer Immunotherapy CIMT (May 3-5, 2023).